Early Registration for Cancer Immunotherapy Winter School Closing Soon
Get Ready for the SITC Spring Scientific
SITC is holding an open call for proposals! SITC leadership wants to hear ideas from its members, which will inspire content for future workshops, webinars, consensus meetings and manuscripts.
Download the new SITC Clinical Practice Guidelines Mobile App! The first and only immunotherapy-specific clinical practice guidelines app featuring expert panel recommendations. Available for FREE for iOS and Android.
SITC’s Value Framework for Phase III Immuno-Oncology Trials
New SITC Clinical Practice Guidelines Published
Targets for Cancer IO: A Deep Dive Series
Celebrate a Decade of Publishing with SITC’s Official Journal
Hear from editors about the state of the field, explore the journal’s major milestones, and read top content.
Dear Women in SITC
I believe it's important to offer opportunities from the Society for Immunotherapy of Cancer (SITC) to women who are looking to advance their careers in immunotherapy. I would like to personally invite you to attend one of these educational ...
Post-doctoral Fellow - Cancer immunology, immunotherapy
Surgery Branch, National Cancer Institute, NIH
NAME OF HIRING OFFICIAL/INVESTIGATOR
Steven A. Rosenberg, M.D., Ph.D.
Seeking a Post-Doctoral Fellow for ...
Surgery Branch/Cancer Immunotherapy Research Fellowships are available at the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under the leadership of Dr. Steven A. Rosenberg.
These fellowships are open to US categorical general ...
Donate today to support early career scientists who are emerging leaders seeking toadvance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org